Therapeutics: L selectin (CD62L; SELL)

Mouse studies suggest a subset of natural killer T (NKT) cells engineered to express tumor antigen-specific chimeric antigen receptors (CARs) could help treat cancer. NKT cells expressing CD62L had lo...